Comparison of transvaginal natural orifice transluminal endoscopic surgery and laparoendoscopic single-site surgery for tubal pregnancy
Résumé fourni par la source
Transvaginal natural orifice transluminal endoscopic surgery (v-NOTES) offers several unique advantages including reduced postoperative pain and improved cosmetic outcomes. This study aimed to evaluate the effectiveness of v-NOTES in the treatment of tubal pregnancy, with a focus on patient outcomes and cost-effectiveness. A retrospective analysis was conducted on 40 cases of tubal pregnancy treated surgically between December 1, 2020 and May 31, 2022. Patients were divided into 2 groups: the v-NOTES group (n = 20), who underwent transvaginal natural orifice transluminal endoscopic surgery, and the control group (n = 20), who underwent laparoscopic single-site surgery (LESS). Key variables including age, body mass index, operative time, intraoperative blood loss, postoperative pain, recovery time, and total costs were evaluated and compared between the 2 groups. Operative time and intraoperative blood loss were comparable between the 2 groups, patients in the v-NOTES group reported significantly lower postoperative pain scores and shorter hospital stays (P < .05). Additionally, the time return to normal activity was markedly shorter in the v-NOTES group compared to the LESS group (16 hours vs 25 hours, respectively). Both procedures demonstrated similar safety profiles; but v-NOTES was associated with a faster recovery and higher patient satisfaction. V-NOTES is a safe and effective minimally invasive surgical option for tubal pregnancy, providing enhanced recovery and improved patient experience compared to LESS.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Comparison of transvaginal natural orifice transluminal endoscopic surgery and laparoendoscopic single-site surgery for tubal pregnancy
- Date Crossref
- 07/11/2025
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.
Institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.